divendres, 22 de febrer del 2019

Abbott touts real-world data for FreeStyle Libre glucose monitor

Abbott's FreeStyle LibreAbbott (NYSE:ABT) presented real-world data this week showing that use of its FreeStyle Libre glucose monitoring system reduced prolonged hypoglycemia and helped users achieve better glucose control.

At the 12th Advanced Technologies & Treatments for Diabetes meeting in Berlin, the company showcased a real-world evidence data set that included roughly 500,000 FreeStyle Libre system users.

Get the full story at our sister site, Drug Delivery Business News.

The post Abbott touts real-world data for FreeStyle Libre glucose monitor appeared first on MassDevice.



from MassDevice https://ift.tt/2EowOOM

Cap comentari:

Publica un comentari a l'entrada